Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Inventory (2023 - 2025)

Bioregenx (BRGX) has 3 years of Inventory data on record, last reported at $109378.0 in Q3 2025.

  • For Q3 2025, Inventory fell 31.09% year-over-year to $109378.0; the TTM value through Sep 2025 reached $109378.0, down 31.09%, while the annual FY2024 figure was $111094.0, 48.93% down from the prior year.
  • Inventory reached $109378.0 in Q3 2025 per BRGX's latest filing, down from $134228.0 in the prior quarter.
  • Across five years, Inventory topped out at $217529.0 in Q4 2023 and bottomed at $109378.0 in Q3 2025.
  • Average Inventory over 3 years is $153582.5, with a median of $142181.0 recorded in 2024.
  • Peak YoY movement for Inventory: tumbled 48.93% in 2024, then decreased 6.74% in 2025.
  • A 3-year view of Inventory shows it stood at $217529.0 in 2023, then crashed by 48.93% to $111094.0 in 2024, then fell by 1.54% to $109378.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory were $109378.0 in Q3 2025, $134228.0 in Q2 2025, and $140438.0 in Q1 2025.